Terminal › Stocks › JNJ

Johnson & Johnson (JNJ) Stock

Healthcare · Drug Manufacturers - General · US

$256.35 +0.21%

Last updated Aug 3, 2026 04:30 UTC

JNJ Key Statistics

Market Cap$617.09B

P/E (TTM)29.70

P/S (TTM)6.30

P/B (TTM)7.72

Revenue (TTM)$97.93B

EPS (TTM)$8.63

Dividend Yield2.36%

ROE (TTM)26.26%

Net Margin21.83%

Gross Margin69.12%

52W High$274.90

52W Low$164.23

Analyst ViewBuy

Price Target$272.69

Employees141,700

Volume4,552,080

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

CEO: Joaquin Duato. Company website

See JNJ live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open JNJ in Terminal See plans

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. ELV Elevance Health Inc.